TOLERX INC has a total of 24 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are IMMUNEXT INC, BHATNAGAR RAKESH and MEDAREX LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | United States | 6 | |
#3 | Canada | 5 | |
#4 | Australia | 3 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Climate change adaptation technologies | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Ponath Paul | 12 |
#2 | Rosenzweig Michael | 11 |
#3 | Rao Patricia | 9 |
#4 | Ponte Jose F | 8 |
#5 | Vaickus Lou | 4 |
#6 | Ponte Joe | 4 |
#7 | Apostolou Irina | 4 |
#8 | Ringler Douglas | 3 |
#9 | Winsor-Hines Dawn | 3 |
#10 | Paglia Michael | 3 |
Publication | Filing date | Title |
---|---|---|
WO2011163566A2 | Methods of treating patients with immune-related diseases | |
WO2011091181A1 | Immunoregulation by anti-ilt5 antibodies and ilt5-binding antibody fragments | |
CN101801413A | Combination therapies employing GITR binding molecules | |
US2010056759A1 | Methods and Compositions for Efficient Removal of Protein A from Binding Molecule Preparations |